Login with your work email address to view charts. No credit card required.
| Art Unit: | 1634 — Chemistry: molecular biology and microbiology |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
435 — Chemistry: molecular biology and microbiology 424 — Drug, bio-affecting and body treating compositions 623 — Prosthesis (i.e., artificial body members), parts thereof, or aids and accessories therefor 514 — Drug, bio-affecting and body treating compositions 123 — Internal-combustion engines 210 — Liquid purification or separation 600 — Surgery 800 — Multicellular living organisms and unmodified parts thereof and related processes |
| Phone: | (571) 272-2840 |
| Email: | teresa.knight@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Biolgy |
| Service: | 14 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 54% over 196 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 77th
|
With Examiner Knight, you have a 54% chance of getting an issued patent by 3 years after the first office action. Examiner Knight is a harder examiner and in the 77th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Knight, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Knight's grant rate is higher than that of Art Unit 1634 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Knight | 1.9 |
| Art Unit 1634 | 2.2 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.